Citation

Zhang X, Tellew JE, Luo Z, Moorjani M, Lin E, Lanier MC, Chen Y, Williams JP, Saunders J, Lechner SM, Markison S, Joswig T, Petroski R, Piercey J, Kargo W, Malany S, Santos M, Gross RS, Wen J, Jalali K, O'Brien Z, Stotz CE, Crespo MI, Díaz JL, Slee DH.: Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's disease. J Med Chem, Volume 51 (22), 2008

Authors

Chen Y, Crespo MI, Díaz JL, Gross RS, Jalali K, Joswig T, Kargo W, Lanier MC, Lechner SM, Lin E, Luo Z, Malany S, Markison S, Moorjani M, O'Brien Z, Petroski R, Piercey J, Santos M, Saunders J, Slee DH., Stotz CE, Tellew JE, Wen J, Williams JP, Zhang X

Journal

J Med Chem

Year

2008

DOI

10.1021/jm800851u

PubMed

18947224

Machine-readable

REST APIRDF